CLOs on the Move

Kolltan

www.kolltan.com

 
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.kolltan.com
  • 300 George St Ste 530
    New Haven, CT USA 06511
  • Phone: 203.773.3000

Executives

Name Title Contact Details

Similar Companies

Academy of Psychosematic Medicine

Academy of Psychosematic Medicine is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Golden Years Medical Inc

Golden Years Medical Inc is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Manta Scientific Solutions

Manta Scientific Solutions is a Highland Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intelligent InSites

Intelligent InSites, Inc. is a leading provider of automation solutions that transform healthcare.

Denny and Associates Inc

Denny & Associates Inc is a O Fallon, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.